EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Time to Death and Donation After Circulatory Death Kidney Transplant Outcomes: Opportunities for Improved Utilization in the United States

Dharesh Raj Amarnath iD, Tanissha Sanjay Raj Kalpana, Georgios Kourounis, Abdullah K Malik, Jennifer Philip, Emily R Thompson, Emily Glover, Gavin J Pettigrew, Chris Callaghan, Neil Sheerin, Colin Wilson, Samuel J Tingle

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Dharesh Raj Amarnath und 11 weiteren Autor:innen. Beteiligte Einrichtung: Newcastle University School of Medicine, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Kidney Transplantation, Tissue and Organ Procurement, Tissue Donors, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Concerns persist that prolonged time to death (TTD) following withdrawal of life‐sustaining treatment may impair organ quality. Although previous European studies have demonstrated that prolonged TTD does not impact post‐transplant kidney graft survival, it remains unclear whether these findings apply to the US donor pool.

Methods

We used OPTN data on adult DCD single‐kidney transplants (2010–2023). Multiple imputation was used for missing data. Multivariable regression models, with restricted cubic splines for non‐linear modelling, were used to evaluate the impact of donor TTD on kidney transplant outcomes.

Results

Median donor TTD was 14 min (IQR, 10–21 min). Donor TTD was not associated with recipient graft survival ( p = 0.469), mortality ( p = 0.528) or 1‐year eGFR ( p = 0.393). These findings were consistent regardless of normothermic regional perfusion use (NRP cohort: n = 1227; non‐NRP cohort: n = 35 328), and within the large ex‐situ hypothermic machine perfusion cohort (HMP‐ cohort: n = 22 218). Only 4.1% of transplanted DCD kidneys were from donors with TTD of over 60 min, and just 0.1% exceeded 120 min.

Conclusions

Increasing donor TTD was not associated with worse post‐kidney‐transplant outcomes within this cohort predominantly comprising donors with TTD 0–60 min. In contrast to this US setting, a previous UK study reported that a higher proportion of transplanted DCD kidneys were from prolonged TTD donors (12.3% from donors TTD >60 min; 4.2% from >120 min). This highlights an opportunity to safely expand the US DCD donor pool, especially in the era of machine perfusion where viability assessment may provide an additional safeguard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationTissue and Organ ProcurementTissue DonorsKidney Failure, ChronicOrgan PreservationGraft RejectionDeathHumansGraft SurvivalFemaleUnited StatesMaleFollow-Up StudiesMiddle AgedPrognosisTime FactorsAdultGlomerular Filtration RateRisk FactorsSurvival RateKidney Function Tests

Stichwörter der Autor:innen

donation after circulatory death (DCD)donor utilizationgraft survivalkidney transplantationmachine perfusionnormothermic regional perfusiontime to death

Autor:innen und Institutionen

  • Newcastle University School of Medicine, Newcastle upon Tyne, UK.
  • NIHR Blood and Transplant Research Unit, Newcastle University and Cambridge University, Newcastle upon Tyne, UK.
  • Institute of Transplantation, The Freeman Hospital, Newcastle upon Tyne, UK.
  • Devarajan Medical Center, Arani, Tamil Nadu, India.
  • Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Division of Transplantation, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

ORCID-Profile: Dharesh Raj Amarnath

Förderung

  • National Institute for Health and Care Research
  • Medical Research Council

Zitieren

APA

Amarnath, D. R., Kalpana, T. S. R., Kourounis, G., Malik, A. K., Philip, J., Thompson, E. R., Glover, E., Pettigrew, G. J., Callaghan, C., Sheerin, N., Wilson, C., & Tingle, S. J. (2026). Time to Death and Donation After Circulatory Death Kidney Transplant Outcomes: Opportunities for Improved Utilization in the United States. Clinical Transplantation. https://doi.org/10.1111/ctr.70548

Vancouver

Amarnath DR, Kalpana TSR, Kourounis G, Malik AK, Philip J, Thompson ER, et al. Time to Death and Donation After Circulatory Death Kidney Transplant Outcomes: Opportunities for Improved Utilization in the United States. Clinical Transplantation. 2026. doi:10.1111/ctr.70548

BibTeX
@article{Amarnath2026,
  author = {Amarnath, Dharesh Raj and Kalpana, Tanissha Sanjay Raj and Kourounis, Georgios and Malik, Abdullah K and Philip, Jennifer and Thompson, Emily R and Glover, Emily and Pettigrew, Gavin J and Callaghan, Chris and Sheerin, Neil and Wilson, Colin and Tingle, Samuel J},
  title = {Time to Death and Donation After Circulatory Death Kidney Transplant Outcomes: Opportunities for Improved Utilization in the United States},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70548}
}
Kostenlos starten →